Anti-Cancer Drug Design

Synthesis, structure and tumour necrosis factor- production-enhancing properties of novel adamantylamino heterocyclic derivatives
pp. 73-80(8)
Authors: Maurin12 J.K.; Lasek3 W.; Górska4 A.; witaj3 T.; Wamil3 M.; Mynarczuk3 I.

The interaction of DNA-targeted platinum phenanthridinium complexes with DNA in human cells
pp. 81-89(9)
Authors: Whittaker J.; McFadyen1 W.D.; Baguley2 B.C.

Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes
pp. 91-98(8)
Authors: Wheate N.J.; Cullinane1 C.; Webster1 L.K.

DNA binding properties of the indolocarbazole antitumor drug NB-506
pp. 99-107(9)
Authors: Carrasco C.; Vezin1 H.; Wilson2 W.D.; Ren3 J.; Chaires3 J.B.

New cytotoxic analogues of annonaceous acetogenins
pp. 109-117(9)
Authors: Rodier S.; Huérou1 Y.L.; Renoux B.; Doyon1 J.; Renard2 P.; Pierré3 A.; Gesson J-P.

Investigations on the biological properties of the lipophilic DHFR-inhibitory benzoprims reveal non-folate modes of action and opportunities for anti-cancer drug design
pp. 119-128(10)
Authors: Croughton K.A.; Matthews C.S.; Griffin1 R.J.

Identification of a novel steroid derivative, NSC12983, as a paclitaxel-like tubulin assembly promoter by 3-D virtual screening
pp. 129-133(5)
Authors: Wu12 J.H.; Batist2 G.

Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells
pp. 135-141(7)
Authors: Talarico12 T.; Cullinane2 C.M.; Gray3 P.J.; Webster2 L.K.; Deacon4 G.B.

The role of ring D in the antitumour antibiotic streptonigrin: metal complexation, DNA binding and topoisomerase inhibition by ABC ring analogues of streptonigrin
pp. 143-153(11)
Author: Anderberg P.I.

The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C
pp. 155-166(12)
Authors: Hood1 K.A.; Bäckström2 B.T.; West34 L.M.; Northcote3 P.T.; Berridge2 M.V.

Synthesis and antitumor activity of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones
pp. 167-174(8)
Authors: Andreani A.; Granaiola M.; Leoni A.; Locatelli A.; Morigi R.; Rambaldi M.; Giorgi1 G.; Salvini1 L.